Janelle D'Alvise's most recent trade in Grace Therapeutics Inc. was a trade of 560,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 22, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Grace Therapeutics Inc | Janelle D'Alvise | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 560,000 | 560,000 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc | Janelle D'Alvise | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 655,500 | 655,500 | - | - | Stock Options (Right to Buy) |